Lai Wang

发表

Pradigastat disposition in humans: in vivo and in vitro investigations

K. Kulmatycki, C. Meyers, A. Upthagrove, 2017, Xenobiotica; the fate of foreign compounds in biological systems.

Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir.

T. Heimbach, Imad Hanna, G. Sunkara, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

P. Jordaan, Priya Chandra, J. Flarakos, 2016, Xenobiotica; the fate of foreign compounds in biological systems.

Evaluation of the Absorption, Metabolism, and Excretion of a Single Oral 1-mg Dose of Tropifexor in Healthy Male Subjects and the Concentration Dependence of Tropifexor Metabolism

R. Woessner, M. Kagan, M. Walles, 2021, Drug Metabolism and Disposition.

A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug–Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients

J. Zhou, S. Rebello, H. Einolf, 2017, Drug Metabolism and Disposition.

A physiologically-based pharmacokinetic modeling approach to predict drug-drug interactions of sonidegib ( LDE 225 ) with perpetrators of CYP 3 A in cancer patients

J. Zhou, S. Rebello, H. Einolf, 2016 .

Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults

N. Sauter, L. Ting, C. Darstein, 2017, Clinical Drug Investigation.

Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

V. Fischer, J. Mangold, D. Howard, 2009, Drug Metabolism and Disposition.

Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse

Amanda Smith, K. Dickman, A. Grollman, 2010, Drug Metabolism and Disposition.

[A clinical study of hyperhomocysteinemia in rheumatological diseases].

Xiaofeng Li, Lai Wang, Wei-hua Zhou, 2005, Zhonghua nei ke za zhi.

Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects

J. Schoepfer, Imad Hanna, F. Hourcade‐Potelleret, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Clinical disposition, metabolism and in vitro drug–drug interaction properties of omadacycline

Imad Hanna, J. Flarakos, J. Mangold, 2017, Xenobiotica; the fate of foreign compounds in biological systems.

Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

Heidi J Einolf, T. Ouatas, S. Rebello, 2018, Drug Metabolism and Disposition.

Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions

Heidi J Einolf, Handan He, J. Mangold, 2017, Drug Metabolism and Disposition.

Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans

J. Mangold, O. Simon, H. Einolf, 2016, Drug Metabolism and Disposition.

Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects

Suman Sen, S. Dhuria, J. Mangold, 2013, Journal of clinical pharmacology.